Department of Surgery Pietro Valdoni, University of Rome Sapienza, Rome, Italy.
Head Neck. 2010 Sep;32(9):1173-7. doi: 10.1002/hed.21313.
Cervical hematoma is hardly a predictable complication of thyroid surgery. Postoperative vomiting has been reported as a likely risk factor.
Five hundred sixty-two patients undergoing thyroidectomy were prospectively enrolled in the study and divided into 2 groups. Patients in group A received ondansetron to prevent postoperative vomiting. In group B, patients with low vomiting risk received ondansetron whereas patients at high risk received ondansetron plus dexamethasone. Postoperative outcomes of the groups were analyzed and compared.
Cervical hematomas developed in 3 patients (0.53%): 2 in group A and 1 in group B. All hematomas occurred after 6 hours. The incidence of postoperative vomiting was 11.4% in group A and 6.4% in group B (p = .04).
Careful hemostasis remains of prime importance in preventing cervical hematoma. Postoperative vomiting has not been confirmed by this study as a risk factor for the development of hematoma. Ambulatory thyroid surgery is not advisable.
甲状腺手术后发生颈部血肿的情况很难预测。术后呕吐被认为是一个可能的危险因素。
562 例甲状腺切除术患者前瞻性纳入研究,并分为 2 组。A 组患者使用昂丹司琼预防术后呕吐。B 组中,低呕吐风险的患者使用昂丹司琼,高风险的患者使用昂丹司琼加地塞米松。分析并比较两组的术后结果。
3 例(0.53%)患者出现颈部血肿:A 组 2 例,B 组 1 例。所有血肿均发生在术后 6 小时后。A 组术后呕吐发生率为 11.4%,B 组为 6.4%(p =.04)。
仔细止血仍然是预防颈部血肿的首要任务。本研究并未证实术后呕吐是血肿发展的危险因素。甲状腺手术不建议门诊进行。